Windlas Biotech Limited (WINDLAS) — Board Meeting | 1 July 2026(2 announcements)

· NSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
1 Board Meeting 🟡 Notable Neutral 📄 PDF

Windlas Biotech announced its 25th AGM on July 23, 2026, via video conference, proposing a final dividend of ₹6.30 per share (126% of face value) and reappointing directors Hitesh Windlass and Prachi Jain Windlass. Dr. Tarashree Singhal will be appointed as an Independent Director for five years, with resolutions on auditor remuneration and director appointments to be voted on. Shareholders must update PAN, residential status, and bank mandates by July 16, 2026, to receive dividends via ECS, while remote e-voting via InstaVote and MUFG Intime is open from July 20-22, 2026, requiring OTP-based login and compliance with SEBI regulations.

2 Board Meeting 🟡 Notable Neutral 📄 PDF

Windlas Biotech announced its 25th AGM on July 23, 2026, via video conference, where shareholders will vote on adopting FY2025-26 financial statements, declaring a final dividend of ₹6.30 per share (126% of face value), and appointing Dr. Tarashree Singhal as an independent director. The record date for dividend eligibility is July 16, 2026, with e-voting open from July 20-22 via MUFG Intime’s InstaVote platform, requiring PAN and demat account updates. Shareholders must confirm voting instructions by July 16, and proxy voting rules apply under SEBI compliance.

About Windlas Biotech Limited (WINDLAS)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,645.02 Cr P/E: 26.4

View full WINDLAS stock details →

📡 Get AI alerts when WINDLAS files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track WINDLAS — Free

📊 More WINDLAS filings

See all WINDLAS filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when WINDLAS files new disclosures

Track WINDLAS filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track WINDLAS — Free

Free account · 2 AI queries/day